Literature DB >> 22768767

[Soft and hard tissue changes after maxillary protraction with skeletal anchorage implant in treatment of Class III malocclusion].

Yao Meng1, Jin Liu, Xin Guo, Kaixiong Deng, Man Liu, Jia Zhou.   

Abstract

OBJECTIVE: To evaluate the soft profile and hard tissue changes after maxillary protraction with skeletal anchorage implant in treatment of Class III malocclusion during growth period.
METHODS: 18 patients with skeletal Class III malocclusion were treated with maxillary protraction for about 9 months, (3.5 +/- 0.1) N, with skeletal anchorage implant and face mask. Cephalometric records were analyzed to assess the changes of maxillo-facial structure of the hard and soft tissue before and after treatment.
RESULTS: All patients' Class III profiles were corrected. Maxillary growth increased, chin clockwise rotated, facial convexity angle increased, lower lip protrusion decreased. Facial vertical height ratio, nasolabial angle, upper lip protrusion and mentolabial sulcus changed unconspicuously. Upper incisors kept in sites, lower incisor upright, maxilla moved forwards. SNA, ANB significantly increased. SNB decreased and the mandible clockwise rotated.
CONCLUSION: The maxilla is effectively protracted without significant rotation by using skeletal anchorage implant. The undesired effects of conventional protraction therapies, such as labial tilt of upper anterior teeth and extrusion of the maxillary molars, are reduced or eliminated with skeletal anchorage implant. These effects can conspicuously correct profiles of the patients with skeletal Class III malocclusion, make the profile more harmonious and aesthetic.

Entities:  

Mesh:

Year:  2012        PMID: 22768767

Source DB:  PubMed          Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi        ISSN: 1000-1182


  1 in total

1.  [Meta-analysis of the efficacy of bone anchorage and maxillary facemask protraction devices in treating skeletal class Ⅲ malocclusion in adolescents].

Authors:  Hui Shi; Hong-Shan Ge; Lu-Yi Chen; Zhi-Hua Li
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2020-02-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.